In comparison to EWSR1-FLI1 and EWSR1-ERG, the secondary genomic landscape of EWSR1-NFATc2 fusion positive sarcomas is significantly different and appears to be driven by genes related to the mTOR pathway. This evidence concerns the gene FLI1 and sarcoma.